Our first CCSVI examinations were performed using Color Echo Doppler and Computer Tomography (CT) phlebography, in which we confirmed the prevalence of the venous pathology amongst MS patients.

We developed specialized protocols to diagnose and assess CCSVI , which includes 3 basic procedures: Color Echo Doppler testing (a non-invasive examination),  MRI CT phlebography (a non-invasive examination), and direct invasive venography. The invasive venography is the gold standard to conclusively diagnose and precisely locate venous stenosis or blockages, which lead to CCSVI.

Upon confirmation of venous stenosis or blockages, we offer endovascular balloon dilatation treatments to resolve the restricted vein to restore normal blood-flow. In cases of resistant stenosis, which doesn’t adequately respond to balloon dilatation treatment, with the consent of our patient’s we offer venous stent implantation.

Our entire examination and treatment process requires a 3 to 4 day hospital stay, and we designed our protocols to be minimally invasive, with a quick recovery period,  and complications are not to be expected.

Our preliminary results are very positive, and we have examined and assessed over 750 patients from Bulgaria, North America and Europe, the majority of which had significant CCSVI. We treated the CCSVI cases with balloon dilation angioplasty and/or endovascular venous stent implantation, the positive clinical outcomes and the patient case data and results are being collected for analysis and scientific research.

Collectively, our medical teams annually diagnose and apply contemporary medical practices to treat thousands of patients with a wide range of cardiovascular and endovascular diseases, therefore we have the proper expertise and practical experience to offer quality and comprehensive CCSVI diagnosis and treatment services.